Mersana Therapeutics, Inc. Reports annual revenue of $36.9 million
Company Records $171,670,000.0 loss
Mersana Therapeutics, Inc. [MRSN] has reported $36.9 million in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $171,670,000.0 .
Also Read:
Based in Cambridge, Massachusetts, Mersana Therapeutics, Inc. operates in the Manufacturing sector.
Related Articles:
Candorium Free Members
Join Candorium to access the full article and more